Altered N-glycosylation in CD45 and regulatory roles of altered N-glycosylation in galectin-1-induced growth inhibition in human diffuse large B cell lymphoma

Oncology Reports

Volumn 13, Issue 1, 2005, Pages 109-114

  Suzuki, Osamu ^a   Nozawa, Yoshihiro ^a   Abe, Masafumi ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

CD45; Galectin 1; Human malignant lymphoma; N glycosylation

Indexed keywords

ANTINEOPLASTIC AGENT; CD45 ANTIGEN; GALECTIN 1; OLIGOSACCHARIDE; SWAINSONINE;

ANIMAL; ARTICLE; B CELL LYMPHOMA; CATTLE; CELL PROLIFERATION; DRUG ANTAGONISM; DRUG EFFECT; GLYCOSYLATION; HUMAN; LARGE CELL LYMPHOMA; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; ANTIGENS, CD45; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CATTLE; CELL LINE, TUMOR; CELL PROLIFERATION; GALECTIN 1; GLYCOSYLATION; HUMANS; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, DIFFUSE; OLIGOSACCHARIDES; SWAINSONINE;

EID: 21644436167     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.13.1.109     Document Type: Article

References (41)

1. Suzuki O, Nozawa Y, Kawaguchi T and Abe M: Phaseolus vulgaris leukoagglutinationg lectin-binding reactivity in human diffuse large B cell lymphoma and its relevance to the patient's clinical outcome: lectin histochemistry and lectin blot analysis. Pathol Int 49: 874-880, 1999.
2. Suzuki O, Nozawa Y, Kawaguchi T and Abe M: Alpha-2,6-sialylation of L-PHA reactive oligosaccharides and expression of N-acetyl glucosaminyltransferase V in human diffuse large B cell lymphoma. Oncol Rep 10: 1759-1764, 2003.
3. Kang R, Saito H, Ihara Y, Miyoshi E, Koyama N, Sheng Y and Taniguchi N: Transcriptional regulation of the N-acetylglucosaminyltransferase V gene in human bile duct carcinoma cells (HuCC-T1) is mediated by Ets-1. J Biol Chem 271: 26706-26712, 1996. (Pubitemid 26359077)
4. Saito H, Nishikawa A, Gu J, Ihara Y, Soejima H, Wada Y, Sekiya C, Niikawa N and Taniguchi N: cDNA cloning and chromosomal mapping of human N-acetylglucosaminyltransferase V. Biochem Biophys Res Commun 198: 318-327, 1994.
5. Murata K, Miyoshi E, Kameyama M, Ishikawa O, Kabuto T, Sasaki Y, Hiratsuka M, Ohigashi H, Ishiguro S, Ito S, Honda H, Takemura F, Taniguchi N and Imaoka S: Expression if N-acetylglucosaminyltransferase V in colorectal cancer correlates with metastasis and poor prognosis. Clin Cancer Res 6: 1772-1777, 2000. (Pubitemid 30305070)
6. Fernandes B, Sagman M, Auger M, Demetrio M and Dennis JW: β1-6 branched oligosaccharides as a marker of tumor progression in human breast and colon neoplasia. Cancer Res 51: 718-723, 1991.
7. Shao DM, Wang QH, Chen C, Shen ZH, Yao M, Zhou XD, Tang ZY and Gu JX: N-acetylglucosaminyltransferase V activity in metastatic models of human hepatocellular carcinoma in nude mice. J Exp Clin Cancer Res 18: 331-335, 1999.
8. Guo H-B, Zhang QS and Chen H: Effects of H-ras and v-sis overexpression on N-aeetylglucosaminyltransferase V and metastasis-related phenotypes in human hepatocarcinoma cells. J Cancer Res Clin Oncol 126: 263-270, 2000. (Pubitemid 30246247)
9. Miyoshi E, Nishikawa A, Ihara Y, Gu J, Sugiyama T, Hayashi N, Fusamoto H, Kamada T and Taniguchi N: N-acetylglucosaminyltransferase III and V messenger RNA levels in LEC rats during hepatocarcinogenesis. Cancer Res 53: 3899-3902, 1993. (Pubitemid 23267685)
10. Nan BC, Shao DM, Chen HL, Huang Y, Gu JX, Zhang YB and Wu ZG: Alteration of N-acetylglucosaminyltransferases in pancreatic carcinoma. Glycoconj J 15: 1033-1037, 1998. (Pubitemid 29129202)
11. Monostori E, Hartyani Z, Ocsovszky I, Hegedus Z, Oravecz T, Kalman M and Ando I: Effect of phytohemagglutinin on CD45 in T cells. Immunol Lett 42: 197-201, 1994.
12. Rabinovich GA, Rubinstein N and Toscano MA: Role of galectins in inflammatory and immunomodulatory processes. Biochim Biophys Acta 1572: 274-284, 2002. (Pubitemid 35246350)
13. Barondes SH, Castronovo V, Cooper DN, Cummings RD, Drickamer K, Feizi T, Gitt MA, Hirabayashi J, Hughes C, Kasai K, Leffler H, Liu FT, Lotan R, Mercurio AM, Monsigny M, Pillai S, Poirer F, Raz A, Rigby PWJ, Rini JM and Wang J: Galectins: a family of animal beta-galactoside-binding lectins. Cell 76: 597-598, 1994. (Pubitemid 24070645)
14. Allen HJ, Gottstine S, Sharma A, Di Cioccio RA, Swank RT and Li H: Synthesis, isolation, and characterization of endogenous beta-galactoside- binding lectins in human leukocytes. Biochemistry 30: 8904-8910, 1991.
15. Barondes SH: Soluble lectins: a new class of extracellular proteins. Science 223: 1259-1264, 1984.
16. Carlow DA, Williams MJ and Ziltener HJ: Modulation of O-glycans and N-glycans on murine CD8 T cells fails to alter Annexin V ligand induction by galectin-1. J Immunol 171: 5100-5106, 2003. (Pubitemid 37432792)
17. Adams L, Scott GK and Weinberg CS: Biphasic modulation of cell growth by recombinant human galectin-1. Biochim Biophys Acta 1312: 137-144, 1996. (Pubitemid 26227444)
18. Rabinovich GA, Daly G, Dreja H, Tailor H, Riera CM, Hrabayashi J and Chernajovsky Y: Recombinant galectin-1 and genetic delivery suppress collagen-induced arthritis via T cell apoptosis. J Exp Med 190: 385-397, 1999. (Pubitemid 29374836)
19. Rabinovich GA, Alonso CR, Sotomayor CE, Durand S, Bocco JL and Riera CM: Molecular mechanisms implicated in galectin-1-induced apoptosis: activation of the AP-1 transcription factor and downregulation of bcl-2. Cell Death Differ 7: 747-753, 2000. (Pubitemid 30599255)
20. Moiseeva EP, Williams B, Goodall AH and Samani N: Galectin-1 integrins with 6-1 subunit of integrin. Biochem Biophys Res Commun 310: 1010-1016, 2003. (Pubitemid 37188723)
21. Perillo NL, Pace KE, Seilhamer JJ and Baum LG: Apoptosis of T cells mediated by galectin-1. Nature 378: 736-739, 1995. (Pubitemid 126647279)
22. Nguyen JT, Evans DP, Galvan M, Pace KE, Leitenberg D, Bui TN and Baum LG: CD45 modulates galectin-1-induced T cell death: regulation by expression of core 2 O-glycans. J Immunol 167: 5697-5707, 2001. (Pubitemid 33062760)
23. Pace KE, Lee C, Stewart PL and Baum LG: Restricted receptor segregation into membrane microdomains occurs on human T cells during apoptosis induced by galectin-1. J Immunol 163: 3801-3811, 1999. (Pubitemid 29450905)
24. Murphy JJ, Stevanin T, Schoendorf DS, Wells V and Mallucci L: β-galactoside binding protein inhibits B cell growth and induces cell apoptosis. Biochem Soc Trans 25: 248S, 1997. (Pubitemid 27261008)
25. Foullit M, Joubert-Caron R, Poirier F, Bourin P, Monostori E, Levi-Strauss M, Raphael M, Bladier D and Caron M: Regulation of CD45-induced signaling by galectin-1 in Burkitt lymphoma B cells. Glycobiology 10: 413-419, 2000. (Pubitemid 30184612)
26. Amano M, Galvan M, He J and Baum LG: The ST6Ga1 I sialyltransferase selectively modifies N-glycans on CD45 to negatively regulate galectin-1-induced CD45 clustering, phosphatase modulation, and T cell death. J Biol Chem 278: 7469-7475, 2003. (Pubitemid 36800753)
27. Konstantinov KN, Robbins BA and Liu FT: Galectin-3, a beta-galactoside-binding animal lectin, is a marker of anaplastic large-cell lymphoma. Am J Pathol 148: 25-30, 1996. (Pubitemid 26019639)
28. Tureci O, Schmitt H, Fadle N, Pfreundschuh M and Sahin U: Molecular definition of a novel human galectin which is immunogenic in patients with Hodgkin's disease. J Biol Chem 272: 6416-6422, 1997. (Pubitemid 27118120)
29. Jaffe ES, Harris NL, Stein H and Vardiman JW: Tumors of hematopoietic and lymphoid tissues. In: World Health Organization Classification of Tumors. IARC Press, Lyon, 2001.
30. Abe M, Nozawa Y, Wakasa H, Ohno H and Fukuhara S: Characterization and comparison of two newly established Epstein-Barr virus-negative lymphoma B-cell lines. Cancer 61: 483-490, 1988.
31. Maeda H, Hirata R, Okuyama M, Thompson A and Tohyama H: Two-dimensional gel analysis of a second family of class II molecules by polymorphic HLA-DR 4,5 and w9 monoclonal antibodies. J Immunol 132: 2478-2484, 1984. (Pubitemid 14137641)
32. Pierce M, Buckhaults P, Chen L and Fregien N: Regulation of N-acetylglucosaminyltransferase V and Asn-linked oligosaccharide B (1,6) branching by a growth factor signaling pathway and effects on cell adhesion and metastatic potential. Glycoconj J 14: 623-630, 1997. (Pubitemid 27353206)
33. Demetriou M, Granovsky M, Quaggin S and Dennis JW: Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation. Nature 409: 733-739, 2001. (Pubitemid 32144520)
34. Chui D, Sellakumar G, Green R, Sutton-Smith M, McQuistan T, Marek K, Morris H, Dell A and Marth J: Genetic remodeling of protein glycosylation in vivo induces autoimmune disease. Proc Natl Acad Sci USA 98: 1142-1147, 2001. (Pubitemid 32121200)
35. Abe M, Suzuki O, Tasaki K, Tominaga K and Wakasa H: Analysis of lectin binding properties on human Burkitt's lymphoma cell lines that show high spontaneous metastasis to distant organs in SCID mice: the binding sites for soybean agglutinin lectin masked by sialylation are closely associated with metastatic lymphoma cells. Pathol Int 46: 977-983, 1996.
36. Suzuki O, Nozawa Y, Kawaguchi T and Abe M: UDP-GlcNAc2-epimerase regulates cell surface sialylation and cell adhesion to extracellular matrix in Burkitt's lymphoma. Int J Oncol 20: 1005-1011, 2002.
37. Suzuki O, Nozawa Y and Abe M: Sialic acids linked to glycoconjugates of Fas regulate the caspase-9-dependent and mitochondria-mediated pathway of Fas-induced apoptosis in Jurkat T cell lymphoma. Int J Oncol 23: 769-774, 2003.
38. Weiss A and Schlessinger J: Switching signals on or off by receptor dimerization. Cell 94: 277-280, 1998. (Pubitemid 28376070)
39. Trowbridge IS: CD45: a prototype for transmembrane protein tyrosine phosphatases. J Biol Chem 266: 23517-23520, 1991.
40. Monostori E, Hartyani Z, Hegedus Z, Ocsovszky I, Pallinger E and Ando I: Microheterogeneity of the cell surface tyrosine phosphatase, CD45RA, on T cells: phytohemagglutinin binding and non-binding fraction of the 220 kDa isoform. Immunol Lett 59: 171-176, 1997. (Pubitemid 27519692)
41. Purido R and Sanchez-Madrid F: Biochemical nature and topographic localization of epitopes defining four distinct CD45 antigen specificities. Conventional CD45, CD45R, 180 kDa (UCHL-1) and 220/205/190 kDa. J Immunol 143: 1930-1936, 1989.